GlassScriptPhysician profile
Jennifer L Carroll
NPI 1306849401
$1,020.45
in general payments reported to CMS, 2019-2025
24 companies · $40.63 in 2025
The $40.63 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $37.62 · 2021: $8.15 · 2022: $91.86 · 2023: $283 · 2024: $248 · 2025: $40.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.00 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $184.83 | 2023-2025 | |
| Abbvie INC. | $139.07 | 2019-2023 | Liletta |
| Astellas Pharma US INC | $132.64 | 2022-2024 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $57.44 | 2023-2024 | Myfembree |
| Mylan Pharmaceuticals INC. | $50.98 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.92 | 2019-2022 | |
| Coopersurgical, INC. | $39.71 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Lupin INC. | $37.72 | 2019 | |
| Exeltis, USA INC. | $35.11 | 2019-2024 | Slynd |
| Roche Diagnostics Corporation | $30.39 | 2019 | |
| Allergan, INC. | $27.72 | 2019 | |
| Amgen INC. | $27.32 | 2019-2020 | |
| Myovant Sciences INC. | $25.59 | 2022 | |
| Organon LLC | $24.20 | 2022-2023 | Nexplanon |
| Sage Therapeutics, LLC | $22.88 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $22.88 | 2023 | |
| Becton, Dickinson and Company | $22.65 | 2024 | Arista Ah Flexitip |
| Hologic Sales and Service, LLC | $17.42 | 2024 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Therapeuticsmd, INC. | $17.19 | 2019 | |
| Shield Therapeutics INC | $15.26 | 2023 | Accrufer |
| Aspira Women'S Health INC | $14.58 | 2024 | Ova1 |
| Amag Pharmaceuticals, INC. | $11.92 | 2019 | |
| Duchesnay USA Incorporated | $11.88 | 2019 | |
| Alydia Health | $8.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.